QuidelOrtho (QDEL) Cash from Investing Activities (2021 - 2026)
QuidelOrtho (QDEL) posted Cash from Investing Activities of -$34.0 million for Q1 2026, up 31.45% sequentially from -$49.6 million in Q4 2025, and up 39.5% YoY from -$24.4 million in Q1 2025.
QuidelOrtho (QDEL) Cash from Investing Activities (2021 - 2026) Analysis & Trends
QuidelOrtho has reported Cash from Investing Activities for 6 years, with the latest figure at -$34.0 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 39.5% year-over-year to -$34.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$170.5 million (up 8.28% YoY) and the FY2025 annual result came in at -$192.7 million, down 28.55% from the prior year.
- Cash from Investing Activities rose to -$34.0 million in Q1 2026 per QDEL's latest filing, from -$49.6 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$20.2 million in Q1 2024 and troughed at -$1.4 billion in Q1 2023.
- A 5-year average of -$134.0 million and a median of -$42.3 million in 2023 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 96.12% in 2023, down 178.95% in 2023.
- Over 5 years, Cash from Investing Activities stood at -$24.7 million in 2022, then sank by 123.08% to -$55.1 million in 2023, then jumped by 31.22% to -$37.9 million in 2024, then plunged by 30.87% to -$49.6 million in 2025, then soared by 31.45% to -$34.0 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods registered -$34.0 million, -$49.6 million, and -$53.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | QuidelOrtho | 1.01 Bn | 885.73 Mn | - | -107.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | -107.30 Mn |
| Jun 28, 2026 | -107.30 Mn |
| Mar 29, 2026 | -34.00 Mn |
| Mar 29, 2026 | -34.00 Mn |
| Dec 28, 2025 | -49.60 Mn |
| Dec 28, 2025 | -49.60 Mn |
| Sep 28, 2025 | -53.90 Mn |
| Sep 28, 2025 | -53.90 Mn |
| Jun 29, 2025 | -33.00 Mn |
| Jun 29, 2025 | -33.00 Mn |
| Mar 30, 2025 | -56.20 Mn |
| Mar 30, 2025 | -56.20 Mn |
| Dec 29, 2024 | -37.90 Mn |
| Dec 29, 2024 | -37.90 Mn |
| Sep 29, 2024 | -56.50 Mn |
| Sep 29, 2024 | -56.50 Mn |
| Jun 30, 2024 | -35.30 Mn |
| Jun 30, 2024 | -35.30 Mn |
| Mar 31, 2024 | -20.20 Mn |
| Mar 31, 2024 | -20.20 Mn |